• Bronchiectasis Increases Risk of Stroke and Cognitive Dysfunction, Study Suggests
  • FDA Advisory Group Set to Review Linhaliq, Potential Non-CF Bronchiectasis Treatment, on Jan. 11
  • Antidepressants Increase Older People’s Risk of Developing Bronchiectasis, Study Reports
  • Pseudomonas aeruginosa Infection in NCFBE Patients Leads to Higher Healthcare Costs, Study Finds
  • Rare Disease Patient Groups Unite to Preserve Orphan Drug Tax Credit in US
  • FDA Panel Opposes Approving Cipro DPI to Treat Non-CF Bronchiectasis
  • Bronchiectasis More Prevalent in US Than Previously Thought, Study Finds
  • Pilot Study to Test Nitric Oxide Gas Treatment on Nontuberculous Mycobacteria Infections
  • Children’s National, NORD Partner to Create Rare Disease ‘Centers of Excellence’
  • Three Factors Raise Risk of Bronchiectasis Patients Developing Drug-resistant Infections, Study Suggests
  • Sleep Disorders Common Among Non-Cystic Fibrosis Bronchiectasis Patients, Study Finds
  • #NORDsummit – Alternatives to Large Placebo Trials, Grant Awards Among Ways FDA Supporting Rare Diseases, Chief Says